Cost-effectiveness of drug-eluting stents: real-world scrutiny of the BASKET trial of real-world usage.
This editorial examines incremental cost-effectiveness analysis as a decision-making tool to guide the allocation of scarce financial resources. BASKET (Basel Stent Kosten Effektivitats Trial) evaluated the cost-effectiveness of drug-eluting stents in a real-world setting. Results of this study are examined in relation to similar assessments and alternative plausible assumptions are explored and presented in the context of real-world sensitivity analysis.
Cooper
Liesl M
LM
Linde-Zwirble
Walter
W
D015906:Angioplasty, Balloon, Coronary; D019917:Blood Vessel Prosthesis Implantation; D003327:Coronary Disease / Q000188:drug therapy / Q000191:economics / Q000628:therapy*; D023903:Coronary Restenosis / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D003692:Delayed-Action Preparations / Q000191:economics; D016503:Drug Delivery Systems / Q000191:economics*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D015607:Stents / Q000191:economics*
D003692:Delayed-Action Preparations